Advertisement
Advertisement
ELVN
Enliven Therapeutics, Inc. Common Stock
49.43
USDSponsored
+4.64
+10.36%
Nov 06, 15:59 UTC -5
Closed
After-Market
46.58
-2.85
-5.78%
Enliven Therapeutics, Inc. Common Stock (ELVN)
Enliven Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 3.43B |
| Beta | 0.34 |
| Earnings Per Share (EPS) | -1.71 |
| Price-to-Book (P/B) Ratio | 4.05 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -18.83% |
| Current Ratio | 45.95% |
| Free Cash Flow | -50.57M |
